DJD supervised this project
Notoginsenoside R1, a novel natural PPAR Agonist, attenuates cognitive deficits in a mouse model of diabetic alzheimers disease through enhancing GLUT4-dependent neuronal glucose uptake
2 Are there any potential side effects of IV therapy
Research involving this compound typically focuses on skin matrix, collagen, and copper peptide signaling research, with attention to receptor activity, cellular signaling, and measurable pathway response in experimental models
Overall, tirzepatide's multifaceted mechanism of action makes it a promising treatment option for individuals with type 2 diabetes and obesity and the above effects may be beneficial for patients with NASH and fatty liver disease, as excess weight and obesity are common risk factors for these conditions